Biologics Symposium: All you need to know
1. Anti-TNFs and anti-integrins: Journey so far
2. JAK inhibition: tofacitinib and beyond
3. Ustekinumab: will it be the game changer?
4. Positioning biologics and small molecules: the current perspective
5. Audience Interaction
6. Launch of IBD-ENC Biologics Registry
Read More
2. JAK inhibition: tofacitinib and beyond
3. Ustekinumab: will it be the game changer?
4. Positioning biologics and small molecules: the current perspective
5. Audience Interaction
6. Launch of IBD-ENC Biologics Registry
- 1
- 2